Heart Transplantation for End-Stage Heart Failure Due to Cardiac Sarcoidosis

Conclusions: Patients with cardiac sarcoidosis undergoing heart transplantation have acceptable long-term outcomes without evidence of recurrence of sarcoidosis in the allograft when maintained on low-dose corticosteroids. Progression of extracardiac sarcoid was uncommon, possibly related to immunosuppression. In patients with cardiac sarcoidosis, heart transplantation is a viable treatment modality.

Source: Transplantation Proceedings - July 1, 2013 Category: Transplant Surgery Authors: D. Perkel, L.S.C. Czer, R.P. Morrissey, A. Ruzza, M. Rafiei, M. Awad, J. Patel, J.A. Kobashigawa Tags: Thoracic Transplantation Source Type: research